Allogeneic stem cell transplantation for myelofibrosis patients aged ≥65 years.
Giulia DaghiaTatjana ZabelinaGaby ZeckUte-Marie von PeinMaximilian ChristopeitChristine WolschkeFrancis AyukNicolaus KrögerPublished in: European journal of haematology (2019)
Reduced intensity conditioning regimen followed by ASCT in older patients with myelofibrosis is a curative treatment option. Outcome is more favorable in patients with no or minimal comorbidities.